Robert Vaters, New York
Robert Vaters is an inspirational and highly experienced leader with a penchant for turnarounds, strategic inflection points, restructure and refinance as well as swift operating improvements. Over the course of his career, Mr. Vaters has spearheaded operations and finance at a variety of companies in the healthcare sector. He has a history in multiple roles across the C-Suite of organizations, and he has both domestic and international experience.
Vaters has served as EVP, CFO and then head of strategy of Inamed Corporation, a $500 million global healthcare company specializing in medical aesthetics that was successfully sold to Allergan for $3.2billion. Next, he was a Founder and General Partner at private equity firm Med Opportunity Partners LLC, where he identified, negotiated, and closed on middle market healthcare buyouts and growth equity investments. In 2008 Robert Vaters joined Orthofix where he held several roles including CFO, COO and ultimately President and CEO and a member of the Board of Directors. Mr. Vaters was also President, CFO and a member of the Board of Directors of Caladrius Biosciences, a publicly held biotech and contract manufacturing company. Earlier in Mr. Vaters career he was Senior Vice President and Treasurer of multi-billion dollar global advertising company Young and Rubicam.